2 Although the number of glucose-lowering agents available to treat T2DM has increased dramatically over the past 10 years, gaps continue to exist in care and outcomes
Women researchers typically use far lower doses, usually 5mg to 10mg weekly, focusing on the metabolic and body composition benefits while minimizing androgenic effects
Ferritin levels below 30 ng/mL have been consistently associated with increased hair shedding, and many patients on GLP-1 therapy drop below this threshold without realizing it
Early observational studies suggested lower colorectal cancer incidence among patients treated with GLP-1 agents compared with those receiving other glucose-lowering therapies
We have to employ lifestyle measures and have them occur in a medical setting with team-based care to have lasting impact." Alexander said that care management can be done in person or via telehealth, depending on patient preferences, the resources available and the reimbursement mechanisms at play
The starting dose of retatrutide in clinical trials is 1 mg once weekly for the first 4 weeks
